Navigation Links
Drug for cluster headaches may cause heart problems
Date:8/13/2007

ST. PAUL, Minn. - A drug increasingly used to prevent cluster headaches can cause heart problems, according to a study published in the August 14, 2007, issue of Neurology, the medical journal of the American Academy of Neurology. Those taking the drug verapamil for cluster headaches should be closely monitored with frequent electrocardiograms (EKGs) for potential development of irregular heartbeats.

Cluster headache is a rare, severe form of headache that is more common in men. The attacks usually occur in cyclical patterns, with frequent attacks over weeks or months generally followed by a period of remission when the headaches stop.

The benefit of taking verapamil to alleviate the devastating pain of cluster headaches has to be balanced against the risk of causing a heart abnormality that could progress into a more serious problem, said study author Peter Goadsby, MD, PhD, DSc, of the National Hospital for Neurology and Neurosurgery in Queen Square, London, UK, and the University of California, San Francisco and a member of the American Academy of Neurology.

The study involved 108 people with an average age of 44. The participants started taking verapamil and then had an EKG and an increase in the dosage of the drug every two weeks until the headaches were stopped or they started having side effects.

A total of 21 patients, or 19 percent, had problems with the electrical activity of the heart, or irregular heartbeats, while taking the drug. Most of the cases were not considered serious; however, one person required a permanent pacemaker due to the problem. A total of 37 percent of the participants had slower than normal heart rates while on the drug, but the condition was severe enough to warrant stopping the use of the drug in only four cases.

Goadsby noted that 217 people taking the drug were initially supposed to take part in the study, but 42 percent of them did not have the EKGs done to monitor their heart activity. Many of them said either they or their local services were reluctant to undertake such frequent tests, or they were not aware of the need for the heart monitoring, he said. Since this drug is relatively new for use in cluster headaches, its possible that some health care providers are not aware of the problems that can come with its use.


'/>"/>
Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
Source:Eurekalert

Related medicine news :

1. Why cluster headaches?
2. Melbourne Cluster Of Brain Tumour Not Due To Radiation From Phone Towers
3. Cluster Headaches Can Be Treated By Nasal Spray
4. Neurostimulation Therapy to ease cluster headaches
5. Snoring Linked To Headaches
6. Finding relief from Excruciating Headaches a challenge
7. Epilepsy Drug May Relieve Chronic Headaches
8. Bright arctic lights to cause headaches
9. Acupuncture May Be An Effective Treatment Against Tension-Headaches
10. Headaches Among Children And Sleep Problems Are Interrelated
11. Middle-Aged Women with Headaches, Often Walk Out With Prescriptions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... MADISON HEIGHTS, MICHIGAN (PRWEB) , ... February 22, ... ... news and analysis of issues related to spine practices, is featuring Michigan neurosurgeon ... Jagannathan is known as one of a small number of neurosurgeons in Michigan ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... and 72 percent of those report that family members or friends have also ... they suffer from hearing loss wear hearing aids. One reason, suggested by 89 ...
(Date:2/22/2017)... ... February 22, 2017 , ... Social media marketing is transitioning ... and health systems. Smith & Jones’ delves into this insight and more in its ... Smith & Jones David Vener meets up with social media strategist and partner of ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a ... that the patient context (age, illness and life choices) should be dissociated from ... occurrence. In addition, all too often, studies regarding health system performance ...
(Date:2/21/2017)... ... February 22, 2017 , ... Author Michèle Wolff has a passion ... household and family to know all about it for optimal health. Wanting to share ... of “ Detox, Digestive and Wellness Solutions ” (published by Balboa Press AU). ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017  Aytu BioScience, Inc. ... commercialization of novel products in the field of urology, ... to up to 42 account managers from 35 currently, ... The sales force expansion is being driven ... and revenues, an indication of increasing acceptance of Natesto,s ...
(Date:2/22/2017)... , Feb. 22, 2017  CVS Pharmacy is the ... of partially hydrogenated oils (PHO), the primary source of ... exclusive store brands food products. The retailer now offers ... free from artificial trans fats. This comes a year and ... deadline of June 2018 for processed foods to be ...
(Date:2/22/2017)... , Feb 22, 2017 Nordic Nanovector ... commercialisation of novel targeted therapeutics for haematological cancers, will announce its ... February 2017. ... presentation by Nordic Nanovector,s senior management team will take place at ... 45, 0250 Oslo Meeting Room: NYLAND The presentation will ...
Breaking Medicine Technology: